SPRY |
ARS Pharmaceuticals, Inc. |
Jun 20, 2024 |
1 |
$0 |
4 |
Jun 24, 2024 |
Director |
RLAY |
Relay Therapeutics, Inc. |
Jun 3, 2024 |
1 |
$0 |
4 |
Jun 5, 2024 |
Director |
SPRY |
ARS Pharmaceuticals, Inc. |
Sep 1, 2023 |
5 |
-$644K |
4 |
Sep 5, 2023 |
Director |
SPRY |
ARS Pharmaceuticals, Inc. |
Aug 3, 2023 |
6 |
-$259K |
4 |
Aug 7, 2023 |
Director |
SPRY |
ARS Pharmaceuticals, Inc. |
Aug 1, 2023 |
6 |
-$322K |
4 |
Aug 3, 2023 |
Director |
SPRY |
ARS Pharmaceuticals, Inc. |
Jul 7, 2023 |
3 |
-$45.1K |
4 |
Jul 7, 2023 |
Director |
SPRY |
ARS Pharmaceuticals, Inc. |
Jul 3, 2023 |
9 |
-$475K |
4 |
Jul 6, 2023 |
Director |
SPRY |
ARS Pharmaceuticals, Inc. |
Jun 27, 2023 |
1 |
$0 |
4 |
Jun 28, 2023 |
Director |
SPRY |
ARS Pharmaceuticals, Inc. |
Jun 1, 2023 |
6 |
-$557K |
4 |
Jun 2, 2023 |
Director |
RLAY |
Relay Therapeutics, Inc. |
May 31, 2023 |
1 |
$0 |
4 |
Jun 1, 2023 |
Director |
RLAY |
Relay Therapeutics, Inc. |
May 24, 2023 |
1 |
$0 |
4 |
May 26, 2023 |
Director |
SPRY |
ARS Pharmaceuticals, Inc. |
Nov 9, 2022 |
7 |
-$654K |
4 |
May 10, 2023 |
Director |
SPRY |
Silverback Therapeutics, Inc. |
Aug 5, 2022 |
2 |
$100K |
4 |
Aug 9, 2022 |
Chief Executive Officer, Director |
NKTX |
Nkarta, Inc. |
Jun 8, 2022 |
1 |
$0 |
4 |
Jun 10, 2022 |
Director |
RLAY |
Relay Therapeutics, Inc. |
May 27, 2022 |
1 |
$0 |
4 |
May 27, 2022 |
Director |
SPRY |
Silverback Therapeutics, Inc. |
May 2, 2022 |
2 |
$0 |
4 |
May 4, 2022 |
Chief Executive Officer, Director |
SPRY |
Silverback Therapeutics, Inc. |
Feb 1, 2022 |
3 |
$0 |
4 |
Feb 2, 2022 |
Chief Executive Officer, Director |
NKTX |
Nkarta, Inc. |
Jun 13, 2021 |
1 |
$0 |
4 |
Jun 15, 2021 |
Director |
RLAY |
Relay Therapeutics, Inc. |
May 19, 2021 |
1 |
$0 |
4 |
May 21, 2021 |
Director |